Jakub Hlávka

Jakub Hlávka is a prominent figure in health economics and policy, currently serving as the Executive Director of the Healthcare Markets Initiative at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California (USC). He is also the Director of the Health Economics, Policy and Innovation Institute (HEPII) at Masaryk University in Brno, Czech Republic, and holds a position as a Clinical Associate Professor (Adjunct) of Population and Public Health Sciences at USC.

Educational Background

Dr. Hlávka earned his Ph.D. from the Pardee RAND Graduate School and holds a master’s degree from Georgetown University’s Edmund A. Walsh School of Foreign Service, along with an undergraduate degree from the University of Economics in Prague.

Research Interests

His research focuses on several critical areas:

• Alzheimer's Disease: Investigating innovative payment models for therapies.
• Health System Reform: Analyzing healthcare inequalities and resilience.
• Emerging Therapies: Studying cell and gene therapies in various medical fields.

Professional Experience

Before his current roles, Dr. Hlávka worked with various organizations, including:

• The RAND Corporation, focusing on national security and healthcare access.
• Genentech, where he was involved in R&D planning.
• The Czech Government on issues related to corruption and finance.

Recognition

Dr. Hlávka has received accolades such as being named a Young Leader by the Aspen Institute Central Europe, a Leader of Tomorrow by the St. Gallen Symposium, and a Global Shaper by the World Economic Forum.

Publications

He has authored numerous articles addressing health economics and policy challenges, particularly related to Alzheimer's disease therapies and alternative payment models.

Overall, Jakub Hlávka is an influential expert in health policy, contributing significantly to both academic research and practical applications in health economics.